Please login to the form below

Not currently logged in
Email:
Password:

talimogene laherparepvec

This page shows the latest talimogene laherparepvec news and features for those working in and with pharma, biotech and healthcare.

Amgen submits melanoma and cholesterol drugs to EMA

Amgen submits melanoma and cholesterol drugs to EMA

Amgen submits melanoma and cholesterol drugs to EMA. Regulator will assess talimogene laherparepvec and evolocumab. ... One of the drugs is talimogene laherparepvec, an oncology treatment that Amgen has submitted for use in the treatment of adults with

Latest news

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Online Physician Communities
Is the pharma industry bad?
Surveys of doctors and the public suggest not...
Salary survey now open - how will you measure up?
Take part for a chance to win a Kindle Fire HD tablet...
Online Physician Communities
M3 and partners win Digital Sales Aid Award
Wins for campaign to overcome limited doctor engagement with pharma-owned websites...